Fact CheckerSign in

NCT07631247Not yet recruiting

iPath for CP Pilot

Improving Screening and Access to Treatment for Depression in Care Partners of People Living With Dementia

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

Depression is a significant problem in care partners of people living with dementia; despite the expansion of options for accessing evidence-based treatments, most care partners of people living with dementia are not screened for depression and do not receive treatment. The objective of this project is to identify a screening method for depression that is feasible and acceptable to care partners and to adapt an innovative pathway to online evidence-based treatment for depression (iPath\*D) as a means of increasing mental health literacy, screening rates and treatment access for care partners of people living with dementia. The results are expected to have a major positive impact by providing proof-of-principle for the use of an online pathway to evidence based treatment with the potential for reaching an unprecedented number of care partners who have unmet mental health needs.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
2 Jun 2026
Start date
Oct 2026
Primary completion date
Mar 2027
Lead sponsor
Dartmouth-Hitchcock Medical Center
NCT number
NCT07631247

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From Oct 2026 to the primary completion date, Mar 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Care partners with:
    • PHQ-8 score \<5
    • Answering positively for question 9 of the PHQ-9 who also screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6b ("Past 3 Months") on the Columbia-Suicide Severity Rating Scale (C-SSRS) and determined by Dr. Mistler, Psychiatrist at DH, not to be eligible.
    • With bipolar disorder or psychosis (documented in the electronic medical record \[EMR\])
    • With significant cognitive impairment (documented in the EMR or self-reported during eligibility screening)
    • With no access to an Android or Apple device
    • For Debrief Interviews:

Other

  • Patients: Participants withdrawn from the 2 Week iPath\*CP Pilot.
  • Clinicians: None.

Who the study is looking for

  • For 2 Week iPath\*CP Pilot:
    • Adults (≥18 years)
    • Care partners of persons with dementia who score ≥5 on the PHQ-8 AND PHQ-9 screen
    • Can communicate in English
    • Have access to an Android based or Apple iOS based phone or tablet capable of running the iPath application.
    • For Debrief Interviews:
  • Care partners: Interviews will be conducted with a purposeful sample of 6 patients already consented into the study at the completion of T1 data collection, ensuring representation by sex (male/female), perceived usability (low/high) of iPath\*CP and race/ethnicity.
  • Clinicians: Interviews will be conducted with clinicians and clinical staff who had patients involved in the project.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.